"Oregon Urology Institute is one of the largest, most advanced urological centers in the Northwest. Oregon Urology Institute provides patients with some of the region’s finest medical experts covering every major urological specialty using proven and leading-edge technologies such as robotic surgery, immunotherapy, and radiation therapy."

During the past decade, Oregon Urology Institute conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 13 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Urology Institute" #1 sponsor was "Dendreon" with 7 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Abbott" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Carolina Research Professionals, LLC" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Urology Institute" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator and "Augmenix, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Urology Institute" are "Prostate Cancer" (16 trials), "Prostatic Neoplasms" (4 trials), "Urinary Bladder Neoplasms" (3 trials), "Bladder Cancer" (2 trials) and "Cancer of the Prostate" (2 trials). Many other conditions were trialed in "Oregon Urology Institute" in a lesser frequency.

Most popular intervention types in "Oregon Urology Institute" are "Drug" (22 trials), "Biological" (11 trials), "Other" (3 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Enzalutamide" (5 trials), "Atrasentan" (3 trials), "Cetrelimab" (3 trials) and "Sipuleucel-T" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Urology Institute" are 30 trials for "Male" genders and 8 trials for "All" genders.

Currently, there are NaN active trials in "Oregon Urology Institute". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Oregon Urology Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Urology Institute, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".